Investigating the causes of Pelvic Inflammatory Disease in women
Official title: Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
Funded at University of Pittsburgh at Pittsburgh · NIH-10668432 · Data updated 2026-11-12
This study is looking at what causes Pelvic Inflammatory Disease (PID) in young women by tracking a group of 1,199 women who are at higher risk for infections, to help find better ways to diagnose and treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 1, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $781,685 |
| NIH project number | 5R01AI139189-04 |
| Project ID | NIH-10668432 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are young women who are at high risk for sexually transmitted infections.
✕Less likely to help
Patients who do not have a history of sexually transmitted infections or those who are not female may not benefit from this research.
What this research studies
This research focuses on understanding the causes of Pelvic Inflammatory Disease (PID), a condition that affects many young women and can lead to serious complications like infertility and chronic pain. The study will follow a group of 1,199 women at high risk for sexually transmitted infections over three years to identify specific bacteria and pathogens associated with PID. Researchers will use advanced techniques, including genetic testing and inflammation analysis, to explore the relationship between various bacteria and the development of PID. By identifying these pathogens, the research aims to improve diagnosis and treatment options for affected women.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for Pelvic Inflammatory Disease, ultimately reducing infertility and chronic pain in women.
How similar studies have gone: While there have been studies on PID, this research is novel in its prospective approach and focus on specific bacteria that have not been extensively studied.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Haggerty, Catherine L — University of Pittsburgh at Pittsburgh
- Study coordinator: Haggerty, Catherine L
Related research
Other NIH-funded projects on the same topics.
-
Glutathionylated products from lipid oxidation in eye disease
This project studies how lipid-oxidation products in the eye might drive age-related macular degeneration and related conditions, by looking at molecules that behave like inflammatory signals.
-
Inflammation risks in clonal hematopoiesis and cancer
This grant studies how clonal hematopoiesis may drive inflammatory diseases and helps predict who is at risk so doctors can prevent complications in people with blood cancers.
-
IgE responses to alpha-gal and how they relate to allergic disease
This project studies why some people develop allergic reactions to mammal products due to alpha-gal and what this means for diagnosing and managing the condition.
-
Alpha‑gal allergy: delayed reactions to red meat and mammal‑derived products
Researchers are looking at why some adults get delayed allergic reactions hours after eating mammal products (alpha‑gal) and how to better diagnose and manage them.
-
A signaling switch that keeps inflammation in check in lupus-like disease
Researchers study how a signaling module in immune cells controls inflammation linked to lupus by examining proteins that turn inflammation on and off.
-
Gut bacteria and steroid hormones in inflammatory bowel disease
A study in people and mice looks at how gut bacteria may change steroids that reduce inflammation in inflammatory bowel disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.